Related Experiment Video
Updated: Jul 17, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Advances in the percutaneous treatment of aortic and mitral valve disease
V Rajagopal1, S R Kapadia, E M Tuzcu
1Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Insights
As the population ages, valvular heart disease (VHD) burden grows. Catheter-based treatments show promise for VHD, expanding options beyond traditional surgery.
Area of Science:
- Cardiology
- Medical Technology
Background:
- Valvular heart disease (VHD) poses a growing healthcare challenge, particularly in aging populations.
- Surgical valve repair and replacement are the established standard of care due to excellent safety and durability.
- Patient comorbidities often increase surgical risks, driving demand for less invasive alternatives.
Purpose of the Study:
- To review the emerging role of catheter-based interventions for valvular heart disease.
- To highlight advancements in percutaneous valve repair and replacement technologies.
Main Methods:
- Review of current literature and early human studies on catheter-based valve interventions.
- Analysis of technological advancements in percutaneous aortic and mitral valve procedures.
Main Results:
- Early human trials of aortic stent-valve prostheses demonstrate encouraging outcomes.
- Percutaneous mitral valve repair techniques, including annuloplasty and leaflet repair, show feasibility in initial studies.
- Technological progress and accumulating experience are expanding the potential of percutaneous treatments for VHD.
Conclusions:
- Catheter-based valve repair and replacement are evolving as viable alternatives for VHD treatment.
- Ongoing clinical trials are crucial for establishing long-term safety, durability, and optimal patient selection for percutaneous VHD therapies.
Abstract:
The healthcare burden of valvular heart disease continues to increase as our population ages. Because of advances in operative techniques and cardiac anesthesiology, surgery has excellent safety and durability for many patients, and surgery remains the gold standard for treating valvular heart disease. Because many patients have comorbidities that increase operative risk, interest in catheter-based valve repair and replacement has grown. Early human experience with aortic stent-valve prostheses has been quite encouraging. For mitral regurgitation, percutaneous annuloplasty and leaflet repair are being developed by numerous companies, and early human studies have demonstrated feasibility of percutaneous repair. Continuing advances in technology and experience promise to expand the role of percutaneous repair and replacement in the treatment of valvular heart disease. Ongoing trials will help define long-term durability and safety, along with appropriate patient selection for percutaneous treatment.
More Related Videos
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Peripheral Artery Disease III: Interprofessional Care
Mitral Valve Prolapse I: Introduction